These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4369583)

  • 1. [Hyperlipoproteinemia and fibrin stabilization using blood factor 13].
    Zöller H; Fromme K; Gross W
    Med Welt; 1974 Aug; 33(34):1303-4. PubMed ID: 4369583
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plasmatic coagulation factors in hyperlipoproteinemias].
    Zöller H; Fromme K; Gross W
    MMW Munch Med Wochenschr; 1974 Feb; 116(5):201-4. PubMed ID: 4360448
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the influence of a fat-modified diet in healthy subjects and in patients with hyperlipoproteinemia].
    Matzkies F; Berg G; Grabner W; Bergner D
    Fortschr Med; 1974 Nov; 92(31):1257-60. PubMed ID: 4373357
    [No Abstract]   [Full Text] [Related]  

  • 4. Bile acid kinetics in relation to sex, serum lipids, body weights, and gallbladder disease in patients with various types of hyperlipoproteinemia;
    Einarsson K; Hellström K; Kallner M
    J Clin Invest; 1974 Dec; 54(6):1301-11. PubMed ID: 4373491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement C3 is a substrate for activated factor XIII that is cross-linked to fibrin during clot formation.
    Richardson VR; Schroeder V; Grant PJ; Standeven KF; Carter AM
    Br J Haematol; 2013 Jan; 160(1):116-9. PubMed ID: 23078103
    [No Abstract]   [Full Text] [Related]  

  • 6. Coupling of fibrin with low density lipoproteins.
    Skrzydlewski Z
    Acta Med Acad Sci Hung; 1976; 33(2):171-7. PubMed ID: 199019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperlipemias].
    Lubetzki J; Mossé A
    Cah Med; 1974 Apr; 15(4):173-85. PubMed ID: 4373145
    [No Abstract]   [Full Text] [Related]  

  • 8. [Primary hyperlipemia: intra-platelet and serum NEFA. Their relation to hypercoagulability].
    Yañez-Polo MA; Muñoz-González J; C-Soriguer-Escofet F; Causse-Prado M; Lissen-Otero E; León-Castro J
    Minerva Med; 1974 Apr; 65(25):1329-39. PubMed ID: 4849473
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnosis and treatment of Type II and Type IV hyperlipoproteinemia in the office practice setting.
    Millett F; Sielski J; Stoll H; Alston N; Gail S
    PA J; 1976; 6(2):54-9. PubMed ID: 10235781
    [No Abstract]   [Full Text] [Related]  

  • 10. Factor XIII consumption as an indicator of thrombin generation.
    Triantaphyllopoulos DC
    J Lab Clin Med; 1974 Jul; 84(1):74-80. PubMed ID: 4833844
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombelastographic studies on factor XIII.
    Schroeder V; Kohler HP
    Thromb Haemost; 2010 Dec; 104(6):1277-9. PubMed ID: 20838747
    [No Abstract]   [Full Text] [Related]  

  • 12. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnosis and treatment of the hyperlipoproteinemias: emphasis on Types IIa, IIb and IV.
    Frommeyer WB
    Ala J Med Sci; 1974 Jul; 11(3):207-14. PubMed ID: 4375414
    [No Abstract]   [Full Text] [Related]  

  • 14. [Blood lipids and lipoproteins in the age aspect and their role in the development of arteriosclerosis].
    Klimov AN
    Vestn Akad Med Nauk SSSR; 1980; (3):45-9. PubMed ID: 7395328
    [No Abstract]   [Full Text] [Related]  

  • 15. [Reliability of simple examination methods for the measurement of fibrin stabilization and factor XIII activity].
    Popat D; Weber G; Wenzel E
    Med Welt; 1972 Sep; 23(40):1387-9. PubMed ID: 4655580
    [No Abstract]   [Full Text] [Related]  

  • 16. [Iron resorption from the digestive tract in patients with primary hyperlipoproteinemia and its influencing by pancreatic extract].
    Brodanová M; Kucerová L; Kordac V
    Sb Lek; 1973 Aug; 75(8):244-50. PubMed ID: 4731466
    [No Abstract]   [Full Text] [Related]  

  • 17. [Systematic study of a median tolerance to a high-fat test diet in hyperlipemia or hyperglyceridemia].
    de Gennes JL; Truffert J; Salmon D; de Tregomain B; Bouchon JP
    Ann Med Interne (Paris); 1969 Dec; 120(12):787-802. PubMed ID: 5377660
    [No Abstract]   [Full Text] [Related]  

  • 18. [Primary hyperlipoproteinemia from its clinical and laboratory aspects. II. Lipid compounds in the blood serum].
    Torbus-Lisiecka B; Wesołowska T; Wira D; Chełstowski K; Bukowska H; Gregorczyk J; Pieczul-Mróz J; Olejak B
    Przegl Lek; 1983; 40(9):677-84. PubMed ID: 6665225
    [No Abstract]   [Full Text] [Related]  

  • 19. A fibrin clot stops low density lipoprotein apheresis.
    Bordin P; Petrucco A; Fiotti N; Giacomello R; Cattin L
    ASAIO J; 1995; 41(2):234-5. PubMed ID: 7640435
    [No Abstract]   [Full Text] [Related]  

  • 20. The primary hyperlipoproteinemias.
    Bybee DE; Hamilton RD
    J Ky Med Assoc; 1974 Dec; 72(12):658-62. PubMed ID: 4373515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.